About this FactMed analysis covering adverse side effect reports of ALFENTANIL patients who developed OEDEMA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 4 individuals taking ALFENTANIL reported OEDEMA to the FDA. A total of 427 ALFENTANIL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALFENTANIL and OEDEMA. In doing so, we compare ALFENTANIL with other drugs that cause OEDEMA, to help you evaluate whether or not ALFENTANIL causes OEDEMA. Likewise, this page shows the most highly-reported side effects of ALFENTANIL, so you can see if OEDEMA ranks among ALFENTANIL's most well-known side effects.
Summary Statistics
Reports of ALFENTANIL causing OEDEMA: 4
Reports of any side effect of ALFENTANIL : 427
Percentage of ALFENTANIL patients where OEDEMA is a reported side effect: 0.9368%

FDA reports of any drug causing OEDEMA : 18153
Average percentage for all medicated patients where OEDEMA is reported as a complication: 0.1138%

Physician opinion on ALFENTANIL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALFENTANIL:
ANAESTHESIA ( 63 patients )
GENERAL ANAESTHESIA ( 52 patients )
SEDATION ( 17 patients )
DRUG USE FOR UNKNOWN INDICATION ( 16 patients )
INDUCTION OF ANAESTHESIA ( 16 patients )
OSTEOTOMY ( 15 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 13 patients )
PAIN ( 6 patients )
SENSORY DISTURBANCE ( 5 patients )
DRUG ABUSE ( 4 patients )
ANAESTHESIA PROCEDURE ( 3 patients )
IN VITRO FERTILISATION ( 3 patients )
DRUG WITHDRAWAL SYNDROME ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
MUSCLE RELAXANT THERAPY ( 1 patients )
PNEUMONIA ( 1 patients )
DISCOMFORT ( 1 patients )
SURGERY ( 1 patients )
LIGHT ANAESTHESIA ( 1 patients )
PERIOPERATIVE ANALGESIA ( 1 patients )
POST PROCEDURAL PAIN ( 1 patients )
COLONOSCOPY ( 1 patients )
RETINAL DETACHMENT ( 1 patients )
VARICOSE VEIN OPERATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with OEDEMA:

ASPIRIN (1936 patients)
FOSAMAX (1632 patients)
LASIX (1619 patients)
VIOXX (1601 patients)
FUROSEMIDE (1162 patients)
HEPARIN SODIUM INJECTION (1069 patients)
LYRICA (1030 patients)
AVANDIA (968 patients)
ZOMETA (965 patients)
GLEEVEC (923 patients)
COUMADIN (878 patients)
PREDNISONE (853 patients)
LIPITOR (743 patients)
LISINOPRIL (729 patients)
MAGNEVIST (642 patients)
NORVASC (638 patients)
DIGOXIN (622 patients)
ATENOLOL (600 patients)
SYNTHROID (600 patients)
OMEPRAZOLE (595 patients)
POTASSIUM CHLORIDE (558 patients)
NEURONTIN (557 patients)
ACETAMINOPHEN (550 patients)
OMNISCAN (543 patients)
NEXIUM (533 patients)
DEXAMETHASONE (515 patients)
PREDNISOLONE (508 patients)
AREDIA (504 patients)
PLAVIX (495 patients)
TRACLEER (487 patients)
DIOVAN (482 patients)
ALLOPURINOL (472 patients)
PROTONIX (467 patients)
METHOTREXATE (464 patients)
SEROQUEL (452 patients)
HYDROCHLOROTHIAZIDE (446 patients)
LEVOTHYROXINE SODIUM (441 patients)
FOLIC ACID (431 patients)
ALBUTEROL (427 patients)
METFORMIN HCL (421 patients)
OXYCONTIN (420 patients)
LORAZEPAM (410 patients)
GABAPENTIN (405 patients)
XANAX (405 patients)
SIMVASTATIN (402 patients)
PRILOSEC (401 patients)
LETAIRIS (399 patients)
ZOLOFT (395 patients)
CELEBREX (394 patients)
SPIRONOLACTONE (389 patients)
IBUPROFEN (385 patients)
REMICADE (381 patients)
ZOCOR (379 patients)
ATIVAN (378 patients)
DECADRON (368 patients)
ACTOS (367 patients)
WARFARIN SODIUM (360 patients)
MORPHINE (360 patients)
INSULIN (359 patients)
VICODIN (357 patients)
PREVACID (353 patients)
LANTUS (351 patients)
HUMIRA (349 patients)
AMBIEN (349 patients)
CYCLOSPORINE (347 patients)
CYCLOPHOSPHAMIDE (347 patients)
LEVAQUIN (344 patients)
PERCOCET (334 patients)
EPOGEN (333 patients)
ALDACTONE (331 patients)
TOPROL-XL (326 patients)
COREG (325 patients)
PAXIL (325 patients)
CRESTOR (320 patients)
PREDNISONE TAB (316 patients)
AMLODIPINE (315 patients)
CYMBALTA (311 patients)
TAXOTERE (308 patients)
OXYCODONE HCL (302 patients)
LEXAPRO (297 patients)
VITAMIN D (293 patients)
METOPROLOL TARTRATE (293 patients)
DILAUDID (277 patients)
VELCADE (267 patients)
ACYCLOVIR (262 patients)
ZOFRAN (261 patients)
CALCIUM (261 patients)
REVLIMID (261 patients)
ZYPREXA (258 patients)
THALIDOMIDE (257 patients)
LORTAB (257 patients)
GLUCOPHAGE (254 patients)
NITROGLYCERIN (249 patients)
ALPRAZOLAM (248 patients)
ZANTAC (246 patients)
FENTANYL (245 patients)
COMPAZINE (244 patients)
ARANESP (244 patients)
VANCOMYCIN (241 patients)
REGLAN (232 patients)
TRAMADOL HCL (229 patients)
SANDOSTATIN LAR (228 patients)
LOVENOX (224 patients)
ADVAIR DISKUS 100/50 (220 patients)
PREMARIN (215 patients)
AMOXICILLIN (213 patients)
AMARYL (213 patients)
GLIPIZIDE (213 patients)
LANSOPRAZOLE (213 patients)
OPTIMARK (211 patients)
PROCRIT (210 patients)
CELEXA (210 patients)
ASCORBIC ACID (208 patients)
COZAAR (206 patients)
ALENDRONATE SODIUM (206 patients)
WELLBUTRIN (205 patients)
NEORAL (205 patients)
LOPRESSOR (205 patients)
REVATIO (205 patients)
IRON (205 patients)
EFFEXOR (202 patients)
CIPROFLOXACIN (201 patients)
MYCOPHENOLATE MOFETIL (200 patients)
SPIRIVA (199 patients)
ZYRTEC (198 patients)
RENAGEL (196 patients)
CLONIDINE (194 patients)
KLOR-CON (194 patients)
ENBREL (194 patients)
GADOLINIUM IN UNSPECIFIED DRUG (193 patients)
ENALAPRIL MALEATE (192 patients)
CALCIUM CARBONATE (191 patients)
COLACE (189 patients)
LAMICTAL (188 patients)
ALTACE (187 patients)
AMIODARONE HCL (187 patients)
FERROUS SULFATE TAB (186 patients)
DURAGESIC-100 (185 patients)
JANUVIA (184 patients)
RISPERDAL (184 patients)
CARVEDILOL (184 patients)
CLONAZEPAM (183 patients)
AVANDAMET (183 patients)
FLUCONAZOLE (183 patients)
PROZAC (179 patients)
METOPROLOL (178 patients)
METHYLPREDNISOLONE (177 patients)
AUGMENTIN '125' (174 patients)
CLARITIN (172 patients)
FLONASE (171 patients)
FAMOTIDINE (170 patients)
ALLEGRA (169 patients)
BACTRIM (167 patients)
MULTI-VITAMINS (166 patients)
HUMALOG (166 patients)
[THERAPY UNSPECIFIED] (165 patients)
EXJADE (165 patients)
CARBOPLATIN (164 patients)
TYLENOL (CAPLET) (162 patients)
CHANTIX (162 patients)
HYDROCODONE (161 patients)
GLYBURIDE (161 patients)
FLAGYL (160 patients)
KLONOPIN (157 patients)
CLINDAMYCIN (156 patients)
HYDROCODONE BITARTRATE (156 patients)
PROGRAF (156 patients)
MORPHINE SULFATE (156 patients)
HEPARIN (155 patients)
BENADRYL (154 patients)
ARIMIDEX (153 patients)
CYTARABINE (153 patients)
SINGULAIR (151 patients)
DIAZEPAM (151 patients)
CEPHALEXIN (149 patients)
MAGNESIUM OXIDE (148 patients)
TAXOL (148 patients)
POTASSIUM (147 patients)
VITAMIN B-12 (147 patients)
LIDOCAINE (146 patients)
ZETIA (145 patients)
PEPCID (145 patients)
TORSEMIDE (145 patients)
FLEXERIL (145 patients)
FLUOROURACIL (144 patients)
RAMIPRIL (143 patients)
VERAPAMIL (142 patients)
HERCEPTIN (141 patients)
AMITRIPTYLINE HCL (141 patients)
THALOMID (141 patients)
TYLENOL (141 patients)
LACTULOSE (140 patients)
MULTIHANCE (139 patients)
XELODA (138 patients)
ZESTRIL (138 patients)
NOVOLOG (137 patients)
METRONIDAZOLE (137 patients)
MULTI-VITAMIN (137 patients)
PRAVACHOL (137 patients)
DIFLUCAN (136 patients)
AMLODIPINE BESYLATE (135 patients)
VYTORIN (135 patients)
ULTRAM (135 patients)
FLOMAX (135 patients)
METFORMIN (135 patients)
NAPROXEN (134 patients)
BISOPROLOL FUMARATE (134 patients)
TACROLIMUS (134 patients)
CHEMOTHERAPEUTICS NOS (133 patients)
NIFEDIPINE (133 patients)
Most common side effects for patients taking ALFENTANIL:
DRUG INTERACTION (75 patients)
DYSTONIA (56 patients)
MYOTONIA (54 patients)
RENAL IMPAIRMENT (42 patients)
SINUS TACHYCARDIA (34 patients)
AGITATION (32 patients)
BACK PAIN (28 patients)
TOXIC EPIDERMAL NECROLYSIS (28 patients)
INFECTION (26 patients)
CARDIAC ARREST (26 patients)
DRUG WITHDRAWAL SYNDROME (26 patients)
THERAPEUTIC AGENT TOXICITY (24 patients)
DRUG EFFECT DECREASED (24 patients)
BRADYCARDIA (23 patients)
TACHYCARDIA (19 patients)
MYOCLONUS (19 patients)
STARING (19 patients)
ANAPHYLACTIC SHOCK (18 patients)
HYPOTENSION (18 patients)
DRUG TOXICITY (18 patients)
MULTI-ORGAN FAILURE (17 patients)
VENTRICULAR FIBRILLATION (16 patients)
BRONCHOSPASM (16 patients)
DEATH (16 patients)
ALANINE AMINOTRANSFERASE INCREASED (15 patients)
OXYGEN SATURATION DECREASED (15 patients)
DRUG EXPOSURE DURING PREGNANCY (15 patients)
HEPATITIS (15 patients)
RESTLESSNESS (14 patients)
PANIC REACTION (14 patients)
LIVER FUNCTION TEST ABNORMAL (14 patients)
ABDOMINAL PAIN (13 patients)
WHITE BLOOD CELL COUNT INCREASED (13 patients)
TUBULOINTERSTITIAL NEPHRITIS (13 patients)
DRUG INEFFECTIVE (13 patients)
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (13 patients)
ANAPHYLACTIC REACTION (12 patients)
HYPERHIDROSIS (12 patients)
NAUSEA (12 patients)
RENAL FAILURE ACUTE (12 patients)
GASTROINTESTINAL HAEMORRHAGE (12 patients)
OEDEMA PERIPHERAL (12 patients)
AGGRESSION (11 patients)
COMA (11 patients)
CYANOSIS (11 patients)
ESCHERICHIA INFECTION (11 patients)
SOMNOLENCE (11 patients)
HAEMOGLOBIN DECREASED (11 patients)
PLEURAL EFFUSION (10 patients)
BLOOD PHOSPHORUS INCREASED (10 patients)
HYPERVENTILATION (10 patients)
CONDITION AGGRAVATED (10 patients)
DISEASE PROGRESSION (10 patients)
HYPOXIA (10 patients)
FEELING ABNORMAL (10 patients)
PULMONARY OEDEMA (9 patients)
SPEECH DISORDER (9 patients)
MYALGIA (9 patients)
ATRIAL FIBRILLATION (9 patients)
PILOERECTION (9 patients)
CAESAREAN SECTION (9 patients)
SEROTONIN SYNDROME (9 patients)
CATATONIA (9 patients)
POST PROCEDURAL COMPLICATION (9 patients)
DYSPNOEA (9 patients)
MYDRIASIS (9 patients)
HEPATIC FAILURE (9 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (8 patients)
AKATHISIA (8 patients)
ANAESTHETIC COMPLICATION (8 patients)
LACERATION (8 patients)
BLOOD ALBUMIN DECREASED (8 patients)
BLOOD BILIRUBIN INCREASED (8 patients)
BLOOD CALCIUM INCREASED (8 patients)
BRAIN OEDEMA (8 patients)
PNEUMONIA (8 patients)
PUPILLARY REFLEX IMPAIRED (8 patients)
ELECTROCARDIOGRAM QT PROLONGED (8 patients)
RHABDOMYOLYSIS (8 patients)
BLISTER (7 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (7 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (7 patients)
HYPERSENSITIVITY (7 patients)
PYREXIA (7 patients)
C-REACTIVE PROTEIN INCREASED (7 patients)
PARAESTHESIA (7 patients)
VOMITING (7 patients)
PREMATURE RUPTURE OF MEMBRANES (7 patients)
SCLERODERMA (7 patients)
RENAL FAILURE (7 patients)
EXTENSOR PLANTAR RESPONSE (7 patients)
FATIGUE (7 patients)
HAEMATEMESIS (7 patients)
SLEEP DISORDER (7 patients)
PREMATURE LABOUR (7 patients)
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED (6 patients)
AMNESIA (6 patients)
PEMPHIGOID (6 patients)
PROCEDURAL COMPLICATION (6 patients)
ASCITES INFECTION (6 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (6 patients)
HYPOCOAGULABLE STATE (6 patients)
BLOOD PRESSURE DECREASED (6 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (6 patients)
VENTRICULAR TACHYCARDIA (6 patients)
HYPERGLYCAEMIA (6 patients)
WOUND SECRETION (6 patients)
ENTEROCOCCAL INFECTION (6 patients)
MOVEMENT DISORDER (6 patients)
SEPSIS (6 patients)
NO THERAPEUTIC RESPONSE (6 patients)
GLASGOW COMA SCALE ABNORMAL (6 patients)
ABDOMINAL SEPSIS (5 patients)
HYPOTONIA (5 patients)
HYPERREFLEXIA (5 patients)
APHASIA (5 patients)
ASCITES (5 patients)
HYPERPARATHYROIDISM (5 patients)
HYPOKALAEMIA (5 patients)
CARDIO-RESPIRATORY ARREST (5 patients)
UNRESPONSIVE TO STIMULI (5 patients)
THROMBOCYTOPENIA (5 patients)
PROPOFOL INFUSION SYNDROME (5 patients)
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION (5 patients)
SCREAMING (5 patients)
ISCHAEMIC STROKE (5 patients)
FALL (5 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (5 patients)
TREMOR (5 patients)
HEMIPLEGIA (5 patients)
SMALL INTESTINAL HAEMORRHAGE (5 patients)
NEUTROPENIA (4 patients)
ACCIDENTAL OVERDOSE (4 patients)
RESUSCITATION (4 patients)
AIRWAY COMPLICATION OF ANAESTHESIA (4 patients)
TRANSAMINASES INCREASED (4 patients)
ARRHYTHMIA (4 patients)
ARTHRALGIA (4 patients)
NO ADVERSE EVENT (4 patients)
BLOOD TRIGLYCERIDES INCREASED (4 patients)
INJURY (4 patients)
MATERNAL DRUGS AFFECTING FOETUS (4 patients)
RESPIRATORY DEPRESSION (4 patients)
MOTOR DYSFUNCTION (4 patients)
MUSCLE RIGIDITY (4 patients)
LABILE BLOOD PRESSURE (4 patients)
CELLULITIS (4 patients)
DELAYED RECOVERY FROM ANAESTHESIA (4 patients)
DEPRESSED LEVEL OF CONSCIOUSNESS (4 patients)
HYPERTENSION (4 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (4 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (4 patients)
PULMONARY EMBOLISM (4 patients)
ECTOPIC PREGNANCY (4 patients)
RASH ERYTHEMATOUS (4 patients)
MELAENA (4 patients)
FOETAL MALPRESENTATION (4 patients)
NEUTROPHILIA (4 patients)
GRAND MAL CONVULSION (4 patients)
SUBARACHNOID HAEMORRHAGE (4 patients)
OEDEMA (4 patients)
ABORTION INDUCED (3 patients)
ANHEDONIA (3 patients)
VARICOSE VEIN OPERATION (3 patients)
PAIN (3 patients)
ANXIETY (3 patients)
APALLIC SYNDROME (3 patients)
MICROSTOMIA (3 patients)
RESPIRATORY FAILURE (3 patients)
BLOOD CREATININE INCREASED (3 patients)
UNEVALUABLE EVENT (3 patients)
PANIC ATTACK (3 patients)
BLOOD POTASSIUM DECREASED (3 patients)
BONE DISORDER (3 patients)
BRAIN DEATH (3 patients)
CARDIAC DISORDER (3 patients)
METABOLIC ACIDOSIS (3 patients)
SKIN REACTION (3 patients)
PANCREATIC ABSCESS (3 patients)
CEREBRAL HAEMORRHAGE (3 patients)
CEREBRAL ISCHAEMIA (3 patients)
CEREBROVASCULAR ACCIDENT (3 patients)
CHOLESTASIS (3 patients)
ORGAN FAILURE (3 patients)
PANCREATITIS (3 patients)
CONVULSION (3 patients)
CYTOLYTIC HEPATITIS (3 patients)
TUMOUR LYSIS SYNDROME (3 patients)
PANCREATIC NECROSIS (3 patients)
DEHYDRATION (3 patients)
DEPRESSION (3 patients)
PROTHROMBIN TIME PROLONGED (3 patients)
DRUG HYPERSENSITIVITY (3 patients)
HYPOGLYCAEMIA NEONATAL (3 patients)
DYSPHASIA (3 patients)
DYSPHONIA (3 patients)
RENAL INJURY (3 patients)
LOCALISED OEDEMA (3 patients)
ELECTROMECHANICAL DISSOCIATION (3 patients)
RAYNAUD'S PHENOMENON (3 patients)
ERYTHEMA (3 patients)
FACE OEDEMA (3 patients)
FEAR (3 patients)
SEX CHROMOSOME ABNORMALITY (3 patients)
SKIN DISCOLOURATION (3 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (3 patients)
HAEMATOMA (3 patients)
HAEMODIALYSIS (3 patients)
THERAPY NON-RESPONDER (3 patients)
HEART RATE INCREASED (3 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALFENTANIL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about OEDEMA and ALFENTANIL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALFENTANIL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALFENTANIL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALFENTANIL experts. If you are a healthcare provider experienced in prescribing ALFENTANIL, please register here.
giCould not connect: